(CTSH) Cognizant Technology - Overview
Sector: Technology | Industry: Information Technology Services | Exchange: NASDAQ (USA) | Market Cap: 24.445m USD | Total Return: -41% in 12m
Industry Rotation: +10.7
Avg Turnover: 399M
EPS Trend: 65.7%
Qual. Beats: 1
Rev. Trend: 84.0%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Cognizant Technology Solutions Corporation (CTSH) is a global professional services provider specializing in IT consulting, technology solutions, and business process outsourcing. The company operates across four primary segments: Financial Services, Health Sciences, Products and Resources, and Communications, Media and Technology. Its technical portfolio includes artificial intelligence, application development, systems integration, and infrastructure management.
The business model relies heavily on long-term managed services and project-based consulting, common in the IT services sector where revenue is often recurring through multi-year outsourcing contracts. As digital transformation accelerates, Cognizant has increasingly focused on AI-led automation and proprietary software platforms to enhance operational efficiency for clients in highly regulated industries like healthcare and banking.
Investors looking for deeper fundamental analysis may find further value in exploring the detailed metrics available on ValueRay.
Headquartered in Teaneck, New Jersey, the firm maintains a global delivery model that leverages offshore technical talent to provide cost-competitive engineering and research services. Strategic partnerships, such as its collaboration with Uniphore Technologies, aim to integrate specialized language models and AI agents into its existing service architecture.
- Financial services and healthcare sector spending cycles dictate core revenue growth
- Large-scale digital transformation and AI consulting contracts drive margin expansion
- Wage inflation and offshore talent competition pressure operational cost structures
- Global enterprise IT budget cuts reduce demand for discretionary consulting projects
- Strategic AI partnerships and platform licensing diversify traditional outsourcing revenue streams
| Net Income: 2.23b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 1.36 > 1.0 |
| NWC/Revenue: 20.16% < 20% (prev 20.60%; Δ -0.44% < -1%) |
| CFO/TA 0.13 > 3% & CFO 2.76b > Net Income 2.23b |
| Net Debt (-412.0m) to EBITDA (4.00b): -0.10 < 3 |
| Current Ratio: 2.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (477.0m) vs 12m ago -3.64% < -2% |
| Gross Margin: 32.06% > 18% (prev 0.34%; Δ 3.17k% > 0.5%) |
| Asset Turnover: 105.8% > 50% (prev 100.6%; Δ 5.17% > 0%) |
| Interest Coverage Ratio: 107.8 > 6 (EBITDA TTM 4.00b / Interest Expense TTM 32.0m) |
| A: 0.21 (Total Current Assets 7.83b - Total Current Liabilities 3.52b) / Total Assets 20.50b |
| B: 0.74 (Retained Earnings 15.27b / Total Assets 20.50b) |
| C: 0.17 (EBIT TTM 3.45b / Avg Total Assets 20.23b) |
| D: 2.77 (Book Value of Equity 15.05b / Total Liabilities 5.43b) |
| Altman-Z'' Score: 7.86 = AAA |
| DSRI: 1.02 (Receivables 4.61b/4.24b, Revenue 21.41b/20.09b) |
| GMI: 1.07 (GM 32.06% / 34.25%) |
| AQI: 1.00 (AQ_t 0.54 / AQ_t-1 0.54) |
| SGI: 1.07 (Revenue 21.41b / 20.09b) |
| TATA: -0.03 (NI 2.23b - CFO 2.76b) / TA 20.50b) |
| Beneish M-Score: -2.93 (Cap -4..+1) = A |
Over the past week, the price has changed by -8.80%, over one month by -21.96%, over three months by -27.32% and over the past year by -41.04%.
- StrongBuy: 4
- Buy: 3
- Hold: 19
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 74 | 57% |
P/E Forward = 9.0498
P/S = 1.142
P/B = 1.6223
P/EG = 0.8459
Revenue TTM = 21.41b USD
EBIT TTM = 3.45b USD
EBITDA TTM = 4.00b USD
Long Term Debt = 535.0m USD (from longTermDebt, last quarter)
Short Term Debt = 173.0m USD (from shortTermDebt, last quarter)
Debt = 1.09b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -412.0m USD (from netDebt column, last quarter)
Enterprise Value = 24.02b USD (24.44b + Debt 1.09b - CCE 1.52b)
Interest Coverage Ratio = 107.8 (Ebit TTM 3.45b / Interest Expense TTM 32.0m)
EV/FCF = 9.72x (Enterprise Value 24.02b / FCF TTM 2.47b)
FCF Yield = 10.28% (FCF TTM 2.47b / Enterprise Value 24.02b)
FCF Margin = 11.54% (FCF TTM 2.47b / Revenue TTM 21.41b)
Net Margin = 10.41% (Net Income TTM 2.23b / Revenue TTM 21.41b)
Gross Margin = 32.06% ((Revenue TTM 21.41b - Cost of Revenue TTM 14.54b) / Revenue TTM)
Gross Margin QoQ = 29.63% (prev 31.11%)
Tobins Q-Ratio = 1.17 (Enterprise Value 24.02b / Total Assets 20.50b)
Interest Expense / Debt = 0.64% (Interest Expense 7.00m / Debt 1.09b)
Taxrate = 23.91% (208.0m / 870.0m)
NOPAT = 2.62b (EBIT 3.45b * (1 - 23.91%))
Current Ratio = 2.23 (Total Current Assets 7.83b / Total Current Liabilities 3.52b)
Debt / Equity = 0.07 (Debt 1.09b / totalStockholderEquity, last quarter 15.07b)
Debt / EBITDA = -0.10 (Net Debt -412.0m / EBITDA 4.00b)
Debt / FCF = -0.17 (Net Debt -412.0m / FCF TTM 2.47b)
Total Stockholder Equity = 15.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.02% (Net Income 2.23b / Total Assets 20.50b)
RoE = 14.79% (Net Income TTM 2.23b / Total Stockholder Equity 15.07b)
RoCE = 22.11% (EBIT 3.45b / Capital Employed (Equity 15.07b + L.T.Debt 535.0m))
RoIC = 16.77% (NOPAT 2.62b / Invested Capital 15.65b)
WACC = 7.99% (E(24.44b)/V(25.54b) * Re(8.33%) + D(1.09b)/V(25.54b) * Rd(0.64%) * (1-Tc(0.24)))
Discount Rate = 8.33% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.39 | Cagr: -2.16%
[DCF] Terminal Value 77.50% ; FCFF base≈2.34b ; Y1≈2.19b ; Y5≈2.03b
[DCF] Fair Price = 78.76 (EV 36.84b - Net Debt -412.0m = Equity 37.25b / Shares 473.0m; r=7.99% [WACC]; 5y FCF grow -8.14% → 3.0% )
EPS Correlation: 65.74 | EPS CAGR: 5.63% | SUE: 1.87 | # QB: 1
Revenue Correlation: 83.97 | Revenue CAGR: 2.66% | SUE: 0.03 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.38 | Chg30d=-1.32% | Revisions=-76% | Analysts=22
EPS next Quarter (2026-09-30): EPS=1.47 | Chg30d=-0.59% | Revisions=-25% | Analysts=22
EPS current Year (2026-12-31): EPS=5.68 | Chg30d=+0.44% | Revisions=+74% | GrowthEPS=+7.6% | GrowthRev=+5.7%
EPS next Year (2027-12-31): EPS=6.16 | Chg30d=+0.39% | Revisions=+30% | GrowthEPS=+8.4% | GrowthRev=+5.1%
[Analyst] Revisions Ratio: -76%